Benzinga
QuidelOrtho (QDEL) stock hits 52-week low as Q1 revenue of $615M-$620M misses targets. China snags and a weak flu season drive 32% decline. Latest Ratings for QDEL Date Firm Action From To Feb 2022 Raymond James Upgrades Outperform Strong Buy Aug 2021 Raymond James Maintains Outperform Jun 2021 Raymond James Maintains Outperform View More Analyst Ratings for QDEL View the Latest Analyst Ratings Importance Rank: 1 read more
Go to News Site